These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19116249)

  • 1. Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.
    Kearney M; Maldarelli F; Shao W; Margolick JB; Daar ES; Mellors JW; Rao V; Coffin JM; Palmer S
    J Virol; 2009 Mar; 83(6):2715-27. PubMed ID: 19116249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences.
    Eriksson EM; Liegler T; Keh CE; Karlsson AC; Holditch SJ; Pilcher CD; Loeb L; Nixon DF; Hecht FM
    PLoS One; 2014; 10(4):e0120787. PubMed ID: 25919393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
    Cornelissen M; van den Burg R; Zorgdrager F; Lukashov V; Goudsmit J
    J Virol; 1997 Sep; 71(9):6348-58. PubMed ID: 9261352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
    Arora SK; Gupta S; Toor JS; Singla A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence evolution of HIV-1 following mother-to-child transmission.
    Ryland EG; Tang Y; Christie CD; Feeney ME
    J Virol; 2010 Dec; 84(23):12437-44. PubMed ID: 20861265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.
    Allen TM; Altfeld M; Geer SC; Kalife ET; Moore C; O'sullivan KM; Desouza I; Feeney ME; Eldridge RL; Maier EL; Kaufmann DE; Lahaie MP; Reyor L; Tanzi G; Johnston MN; Brander C; Draenert R; Rockstroh JK; Jessen H; Rosenberg ES; Mallal SA; Walker BD
    J Virol; 2005 Nov; 79(21):13239-49. PubMed ID: 16227247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 evolution following transmission to an HLA-B*5801-positive patient.
    O'Connell KA; Xu J; Durbin AP; Apuzzo LG; Imteyaz H; Williams TM; Ray SC; Margolick JB; Siliciano RF; Blankson JN
    J Infect Dis; 2009 Dec; 200(12):1820-4. PubMed ID: 19909081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary.
    Mezei M; Ay E; Koroknai A; Tóth R; Balázs A; Bakos A; Gyori Z; Bánáti F; Marschalkó M; Kárpáti S; Minárovits J
    AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1243-7. PubMed ID: 21453184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
    Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
    J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC.
    Wood N; Bhattacharya T; Keele BF; Giorgi E; Liu M; Gaschen B; Daniels M; Ferrari G; Haynes BF; McMichael A; Shaw GM; Hahn BH; Korber B; Seoighe C
    PLoS Pathog; 2009 May; 5(5):e1000414. PubMed ID: 19424423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evolution of human immunodeficiency virus type 1 upon transmission between human leukocyte antigen disparate donor-recipient pairs.
    Navis M; Matas DE; Rachinger A; Koning FA; van Swieten P; Kootstra NA; Schuitemaker H
    PLoS One; 2008 Jun; 3(6):e2422. PubMed ID: 18560583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition.
    Mueller SM; Spriewald BM; Bergmann S; Eismann K; Leykauf M; Korn K; Walter H; Schmidt B; Arnold ML; Harrer EG; Kaiser R; Schweitzer F; Braun P; Reuter S; Jaeger H; Wolf E; Brockmeyer NH; Jansen K; Michalik C; Harrer T;
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):109-17. PubMed ID: 21107269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.
    Kousiappa I; van de Vijver DA; Demetriades I; Kostrikis LG
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):23-35. PubMed ID: 19182918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
    Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM
    J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.